Squarepoint
STOK icon

Squarepoint’s Stoke Therapeutics STOK Stock Holding History

Squarepoint’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$444K Sell
17,082
-12,228
-42% -$369K ﹤0.01% 3476
2026
Q2 		$959K Buy
+29,310
New +$941K ﹤0.01% 2928
2025
Q3 		– Sell
-23,458
Closed -$266K – 4977
2025
Q2 		$266K Buy
+23,458
New +$223K ﹤0.01% 3776
2025
Q1 		– Sell
-120,242
Closed -$1.33M – 5381
2024
Q4 		$1.33M Buy
120,242
+7,575
+7% +$93.1K ﹤0.01% 2801
2024
Q3 		$1.38M Buy
112,667
+97,625
+649% +$1.38M ﹤0.01% 2352
2024
Q2 		$203K Sell
15,042
-36,055
-71% -$487K ﹤0.01% 3654
2024
Q1 		$690K Buy
51,097
+32,001
+168% +$194K ﹤0.01% 2840
2023
Q4 		$100K Buy
19,096
+3,886
+26% +$16.6K ﹤0.01% 3754
2023
Q3 		$59.9K Buy
+15,210
New +$100K ﹤0.01% 3617
2023
Q2 		– Sell
-17,851
Closed -$149K – 3994
2023
Q1 		$149K Buy
+17,851
New +$161K ﹤0.01% 2894
2021
Q3 		– Sell
-6,495
Closed -$219K – 3407
2021
Q2 		$219K Sell
6,495
-4,217
-39% -$149K ﹤0.01% 2757
2021
Q1 		$416K Buy
+10,712
New +$610K ﹤0.01% 2157
2020
Q4 		– Sell
-10,837
Closed -$363K – 3247
2020
Q3 		$363K Buy
+10,837
New +$309K ﹤0.01% 1661
2020
Q1 		– Sell
-20,286
Closed -$574K – 2483
2019
Q4 		$574K Sell
20,286
-1,413
-7% -$35.5K ﹤0.01% 1688
2019
Q3 		$466K Buy
+21,699
New +$605K ﹤0.01% 1659

Other funds holding STOK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
SYM Financial Corp
SYM Financial Corp Winona Lake, Indiana $1.31B AUM 18.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Squarepoint's STOK Position: Q3 2026 in Review

Squarepoint reduced its Stoke Therapeutics (STOK) stake by 42% in Q3 2026, selling an estimated $369K and leaving 17,082 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #3476.

Squarepoint first reported a position in STOK in Q3 2019 and has held it in 15 quarters since. The position peaked at $1.38M in Q3 2024. 61 funds tracked by Wall St. Rank hold STOK as of Q3 2026.

  • Squarepoint held 17,082 shares of Stoke Therapeutics worth $444K as of Q3 2026.
  • Squarepoint sold 12,228 Stoke Therapeutics shares in Q3 2026, an estimated $369K.
  • Stoke Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3476 holding.
  • Squarepoint first reported a position in Stoke Therapeutics in Q3 2019 and has held it in 15 quarters since.
  • Squarepoint's Stoke Therapeutics position peaked at $1.38M in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.